scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.CIR.103.19.2361 |
P698 | PubMed publication ID | 11352884 |
P50 | author | Emelia J. Benjamin | Q28754501 |
Lewis Kuller | Q88077314 | ||
P2093 | author name string | Elston RC | |
Tracy RP | |||
Albert C | |||
Schwartz PJ | |||
Zipes DP | |||
Muller JE | |||
Marbán E | |||
Siscovick DS | |||
George AL Jr | |||
MacCluer JW | |||
Zareba W | |||
Boineau R | |||
Jouven X | |||
Spooner PM | |||
P433 | issue | 19 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2361-2364 | |
P577 | publication date | 2001-05-01 | |
P1433 | published in | Circulation | Q578091 |
P1476 | title | Sudden cardiac death, genes, and arrhythmogenesis : consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I | |
P478 | volume | 103 |
Q37089729 | A genetic framework for improving arrhythmia therapy. |
Q37458988 | Arrhythmia pharmacogenomics: methodological considerations. |
Q35537734 | Association between short term exposure to fine particulate matter and heart rate variability in older subjects with and without heart disease |
Q34111355 | Cardiac arrhythmia:in vivoscreening in the zebrafish to overcome complexity in drug discovery |
Q37561723 | Changes in ventricular repolarization duration during typical daily emotion in patients with Long QT syndrome |
Q84879425 | Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention |
Q34095165 | Defining a new paradigm for human arrhythmia syndromes: phenotypic manifestations of gene mutations in ion channel- and transporter-associated proteins |
Q34640857 | Early identification of risk factors for sudden cardiac death |
Q54484912 | Effects of lüfukang capsules on coronary artery ligation-induced arrhythmia in dogs. |
Q35754355 | Efficient Generation of Cardiac Purkinje Cells from ESCs by Activating cAMP Signaling |
Q48327941 | Efficient Generation of Cardiac Purkinje-like Cells from Embryonic Stem Cells by Activating cAMP Signaling |
Q28072276 | Epidemiology and genetics of ventricular fibrillation during acute myocardial infarction |
Q35684262 | Genetic Polymorphisms as Risk Stratification Tool in Primary Preventive ICD Therapy |
Q39121822 | Genetic isolation of stem cell-derived pacemaker-nodal cardiac myocytes |
Q35076999 | Genetic modifiers of cardiac arrhythmias. |
Q34548827 | Hemostatic and inflammatory markers as risk factors for coronary disease in the elderly |
Q36722100 | Implantable cardioverter defibrillators for prevention of sudden cardiac death |
Q28510070 | Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor |
Q37364043 | Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults |
Q34558607 | Out-of-hospital cardiac arrests and outdoor air pollution exposure in Copenhagen, Denmark |
Q36691828 | Post-transcriptional alterations in the expression of cardiac Na+ channel subunits in chronic heart failure. |
Q63359102 | Quantitative trait loci for electrocardiographic parameters and arrhythmia in the mouse |
Q38073317 | Recent advances in in vivo screening for antiarrhythmic drugs |
Q64998419 | Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator. |
Q24814764 | Repolarization changes induced by air pollution in ischemic heart disease patients |
Q79105456 | Risk stratification and management of sudden cardiac death: a new paradigm |
Q33827123 | Risk stratification for sudden cardiac death: current status and challenges for the future |
Q90579238 | Sleep Apnea and Sudden Cardiac Death |
Q30433543 | Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop |
Q37238606 | Sudden cardiac death: epidemiology and risk factors. |
Q74431200 | The problem, challenge and opportunity of genetic heterogeneity in monogenic diseases predisposing to sudden death |
Q33905030 | Unraveling monogenic channelopathies and their implications for complex polygenic disease |
Q64894770 | Using Zebrafish for High-Throughput Screening of Novel Cardiovascular Drugs. |
Search more.